This study aims to provide evidence concerning the safety and efficacy of motherwort injection in real-world settings.
Study Type
OBSERVATIONAL
Enrollment
20,000
Patients will be given motherwort injection according to their disease condition in the real world. The investigator only can record the information on the usage of the drug and the relevant medications without any interventions.
The type and incidence of adverse events.
Time frame: From the initiation of medication to 7 days after cessation.
Bleeding control.
Including:1. Hysteroscopic surgery: the intraoperative blood loss, the postoperative blood loss, the cumulative bleeding time. 2.Uterine fibroid resection: the intraoperative blood loss, the postoperative blood loss, the cumulative bleeding time.
Time frame: From the commencement of the surgery to the end of bleeding event, assessed up to 1 year.
The incidence of postpartum hemorrhage.
Postpartum hemorrhage is defined as a blood loss of ≥500 ml following vaginal delivery or ≥1000 ml following cesarean delivery, or the presence of symptoms or signs of hypovolemia associated with blood loss within 24 hours .
Time frame: From the completion of the surgery to 24 hours following the delivery of the fetus.
The post-abortion recovery.
The interval time to the resumption of menstruation post-surgery.
Time frame: From the completion of the abortion to the subsequent onset of menstruation, assessed up to 1 year.
The incidence of post-abortion bleeding.
The cumulative days of postoperative bleeding.
Time frame: From the completion of the abortion to the end of bleeding event.
The types and incidence of adverse reactions.
Time frame: From the initiation of medication to 7 days after cessation.
Analysis of factors associated with adverse reactions.
Time frame: From the initiation of medication to 7 days after cessation.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The menstrual adjustment.
Ovulatory dysfunction-related abnormal uterine bleeding: utilizing a treatment satisfaction assessment (0 = dissatisfied; 1 = neutral; 2 = somewhat satisfied; 3 = very satisfied).
Time frame: From the initiation of medication to menstruation returns to normal or the treatment is completed, whichever came first, assessed up to 1 year.
The uterine retraction status.
Including:1.Rate of poor uterine involution: poor uterine involution is defined as the persistence of lochia beyond 42 days postpartum. 2. Duration of lochia cessation.
Time frame: From the the postpartum to the end of bleeding event, assessed up to 1 year.